Medtronic (MDT) earnings history
Most recent quarter
- Fiscal period
- Q1 2027
- Period end
- Jul 31, 2026
- EPS actual
- $1.45
- EPS estimate
- $1.39
- EPS surprise
- +4.44%
- Revenue surprise
- +2.20%
- Revenue
- $9.8B
- Revenue estimate
- $9.5B
- Reported
- Sep 1, 2026
Medtronic reported fiscal Q1 2027 results on September 1, 2026. Earnings per share were $1.45, beating the $1.39 estimate by 4.44%. Revenue was $9.8 billion, 2.20% above the $9.5 billion consensus. Compared with fiscal Q1 2026, EPS rose about 15% from $1.26 and revenue rose about 14% from $8.6 billion.
The table covers 13 quarters, back to fiscal Q1 2024. Annual EPS rose from $5.21 in fiscal 2024 to $5.50 in 2025 and $5.53 in 2026. Annual revenue grew from $32.4 billion to $33.6 billion and then $36.4 billion. Fiscal Q4 was the strongest EPS quarter in each complete year, and Q4 2025 holds the high in the table at $1.62. Fiscal Q1 has been the weakest each year, yet Q1 2027 matched the top revenue figure here at $9.8 billion, level with Q4 2026. Medtronic beat EPS estimates in all 13 quarters, by margins between 0.63% and 8.16%.
Medtronic reported fiscal Q2 between November 18 and November 21 in each of the past three years. That points to mid-to-late November 2026 for the next report. It will show whether the year-over-year gains of fiscal Q1 carry into the second quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2027 | Sep 1, 2026 | $1.39 | $1.45 | +4.44% | $9.8B | SEC |
| Q4 2026 | Jun 3, 2026 | $1.54 | $1.55 | +0.64% | $9.8B | SEC |
| Q3 2026 | Feb 17, 2026 | $1.34 | $1.36 | +1.82% | $9.0B | SEC |
| Q2 2026 | Nov 18, 2025 | $1.31 | $1.36 | +3.49% | $9.0B | SEC |
| Q1 2026 | Aug 19, 2025 | $1.23 | $1.26 | +2.53% | $8.6B | SEC |
| Q4 2025 | May 21, 2025 | $1.58 | $1.62 | +2.46% | $8.9B | SEC |
| Q3 2025 | Feb 18, 2025 | $1.36 | $1.39 | +2.23% | $8.3B | SEC |
| Q2 2025 | Nov 19, 2024 | $1.25 | $1.26 | +0.83% | $8.4B | SEC |
| Q1 2025 | Aug 20, 2024 | $1.20 | $1.23 | +2.59% | $8.0B | SEC |
| Q4 2024 | May 23, 2024 | $1.45 | $1.46 | +0.63% | $8.6B | SEC |
| Q3 2024 | Feb 20, 2024 | $1.26 | $1.30 | +3.04% | $8.1B | SEC |
| Q2 2024 | Nov 21, 2023 | $1.18 | $1.25 | +5.78% | $8.0B | SEC |
| Q1 2024 | Aug 22, 2023 | $1.11 | $1.20 | +8.16% | $7.7B | SEC |
Quarterly revenue
Frequently asked questions
When did Medtronic (MDT) last report earnings?
Medtronic last reported on Sep 1, 2026, covering fiscal Q1 2027.
Did MDT beat earnings estimates?
Yes. Medtronic reported EPS of $1.45 for Q1 2027 against a $1.39 estimate — a 4.44% beat.
How much revenue did MDT report last quarter?
Medtronic reported $9.8B in revenue for Q1 2027, against a consensus estimate of $9.5B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.